Dr Caterina Bendotti
Mario Negri Institute for Pharmacological Research (IRFMN)
"LESSONS FROM COVID-19: Implications for basic and translational research"
Caterina Bendotti has been Head of the Molecular Neurobiology Laboratory at the Mario Negri Institute for Pharmacological Research (IRFMN) since 1998. After gaining a PhD in Neuropharmacology in 1986, she spent two years as post doc at the Developmental Genetics Lab of Johns Hopkins University, Baltimore, where her interest in studying genetically modified mice as models of neurodegenerative diseases started. She then developed specific expertise in the study of animal models of familial ALS, in particular the SOD1 mutant transgenic rodents.
Her research interest is to understand the mechanisms underlying the disease course variability in ALS and to identify biomarkers and specific target for disease progression modifying therapy.
She actively contributed in establishing the international guidelines for preclinical animal research in ALS/MND and served as a member of scientific advisory boards for ALS-related associations and meetings. She is the author of more than 160 papers.